oratie Prins 1..21 - Oratiereeks

Referenties
Akkerman A.E., Kuyvenhoven M.M., van der Wouden J.C., Verheij T.J. ‘Determinants
of antibiotic overprescribing in respiratory tract infections in general practice.’
J Antimicrob Chemother 2005; 56: 930-936
‘Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination
antiretroviral therapy in high-income countries: a collaborative analysis of
14 cohort studies.’ Lancet 2008; 372: 293-299
Bruin M. de, Hospers H.J., van den Borne H.W., Kok G., Prins J.M. ‘Theory- and evidence-based
intervention to improve adherence to antiretroviral therapy among
HIV-infected patients in the Netherlands: a pilot study.’ AIDS Patient Care STDS
2005; 19: 384-394
Cals J.W., Butler C.C., Hopstaken R.M., Hood K., Dinant G.J. ‘Effect of point of care
testing for C reactive protein and training in communication skills on antibiotic
use in lower respiratory tract infections: cluster randomised trial.’ BMJ 2009; 338:
b1374
Deschepper R., Vander Stichele R.H., Haaijer-Ruskamp F.M. ‘Cross-cultural differences
in lay attitudes and utilisation of antibiotics in a Belgian and a Dutch city.’ Patient
Educ Couns 2002; 48: 161-169
Fung C.H., Lim Y.W., Mattke S., Damberg C., Shekelle P.G. ‘Systematic review: the
evidence that publishing patient care performance data improves quality of care.’
Ann Intern Med 2008; 148: 111-123
Goossens H., Ferech M., Vander Stichele R., Elseviers M., ESAC Project Group. ‘Outpatient
antibiotic use in Europe and association with resistance: a cross-national database
study.’ Lancet 2005; 365: 579-587
Hermanides H.S., Hulscher M.E., Schouten J.A., Prins J.M., Geerlings S.E. ‘Development
of quality indicators for the antibiotic treatment of complicated urinary tract
infections: a first step to measure and improve care.’ Clin Infect Dis 2008; 46: 703-
711
Schouten J.A. Improving the quality of antibiotic use for respiratory tract infections at
hospitals. Academisch Proefschrift, Nijmegen, 2006
SWAB. NethMap 2009 – Consumption of antimicrobial agents and antimicrobial resistance
among medically important bacteria in the Netherlands, p. 52,p.32
A TALE OF TWO CITIES 21